FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [18F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-head comparison had been performed to explore the potential utility of FAPI tracers in clinical practice. FAPI-based radiopharmaceuticals have shown promising results globally, in particular in detecting peritoneal carcinomatosis, but studies with wider populations are needed to better understand all the advantages of these new radiopharmaceuticals.
Guglielmo P., Alongi P., Baratto L., Abenavoli E., Buschiazzo A., Celesti G., et al. (2023). Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature [10.3390/life13091821].
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
Alongi P.;
2023-08-01
Abstract
FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [18F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-head comparison had been performed to explore the potential utility of FAPI tracers in clinical practice. FAPI-based radiopharmaceuticals have shown promising results globally, in particular in detecting peritoneal carcinomatosis, but studies with wider populations are needed to better understand all the advantages of these new radiopharmaceuticals.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET- A Systematic Review of the Literature.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
2.98 MB
Formato
Adobe PDF
|
2.98 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
